We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Analyst Predicts Black Box Warning For Byetta

Law360 (September 3, 2008, 12:00 AM EDT) -- Amid cases of severe pancreatitis in patients taking the diabetes drug Byetta — and two deaths linked to the injectable medication — a financial analyst said Tuesday that the U.S. Food and Drug Administration might soon require a top-level warning label.

"We think Byetta could get a black box pancreatitis warning," analyst Adam Cutler of Canaccord Adams Inc. said in a research note, which also stated that “the FDA suspects Byetta causes pancreatitis.”

Amylin Pharmaceuticals had no immediate comment on the matter Wednesday.

In a statement...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.